Crinetics Pharmaceuticals Inc (CRNX) Insider Trading
- $45,793,090.74
- $86,374,036.93
- March 16, 2026
- Stephen F Betz
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 16, 2026 | COO | 9,911 | $37.37 | Sell | $370,374.07 | |
| March 16, 2026 | Insider | 10,612 | $37.37 | Sell | $396,570.44 | |
| March 16, 2026 | CEO | 21,981 | $37.37 | Sell | $821,429.97 | |
| March 12, 2026 | Director | 5,000 | $36.15 | Sell | $180,750.00 | |
| March 3, 2026 | CFO | 6,713 | $39.67 | Sell | $266,304.71 | |
| March 3, 2026 | Director | 3,000 | $39.67 | Sell | $119,010.00 | |
| Aug. 22, 2025 | Insider | 30,000 | $30.43 | Sell | $912,900.00 | |
| Aug. 20, 2025 | Insider | 6,492 | $29.18 | Sell | $189,436.56 | |
| June 12, 2025 | Insider | 97,483 | $32.23 | Sell | $3,141,877.09 | |
| March 19, 2025 | CEO | 17,338 | $34.20 | Sell | $592,959.60 | |
| March 19, 2025 | Insider | 2,515 | $34.20 | Sell | $86,013.00 | |
| March 19, 2025 | COO | 7,162 | $34.20 | Sell | $244,940.40 | |
| Feb. 3, 2025 | Insider | 5,000 | $39.07 | Sell | $195,350.00 | |
| Nov. 22, 2024 | COO | 501 | $56.52 | Sell | $28,316.52 | |
| Oct. 3, 2024 | Insider | 14,375 | $54.63 | Sell | $785,306.25 | |
| Sept. 26, 2024 | CFO | 25,000 | $51.11 | Sell | $1,277,750.00 | |
| Sept. 10, 2024 | Insider | 1,035 | $51.50 | Sell | $53,302.50 | |
| Aug. 26, 2024 | Insider | 3,000 | $53.19 | Sell | $159,570.00 | |
| July 25, 2024 | CFO | 19,056 | $53.88 | Sell | $1,026,737.28 | |
| July 25, 2024 | Insider | 3,000 | $53.43 | Sell | $160,290.00 | |
| July 15, 2024 | CFO | 25,000 | $55.00 | Sell | $1,375,000.00 | |
| July 15, 2024 | COO | 27,000 | $55.00 | Sell | $1,485,000.00 | |
| July 10, 2024 | Insider | 3,000 | $48.55 | Sell | $145,650.00 | |
| July 5, 2024 | Insider | 15,000 | $44.08 | Sell | $661,200.00 | |
| July 3, 2024 | Insider | 14,375 | $44.87 | Sell | $645,006.25 | |
| June 28, 2024 | CFO | 32,129 | $43.61 | Sell | $1,401,145.69 | |
| June 26, 2024 | COO | 956 | $44.38 | Sell | $42,427.28 | |
| June 24, 2024 | Insider | 9,500 | $45.73 | Sell | $434,435.00 | |
| June 21, 2024 | Insider | 15,000 | $44.66 | Sell | $669,900.00 | |
| June 10, 2024 | Insider | 3,000 | $43.86 | Sell | $131,580.00 | |
| May 28, 2024 | Insider | 3,000 | $47.49 | Sell | $142,470.00 | |
| May 10, 2024 | Insider | 3,000 | $49.43 | Sell | $148,290.00 | |
| May 8, 2024 | CEO | 107,448 | $49.40 | Sell | $5,307,931.20 | |
| April 15, 2024 | Insider | 14,375 | $44.47 | Sell | $639,256.25 | |
| April 4, 2024 | CEO | 40,951 | $49.17 | Sell | $2,013,560.67 | |
| March 28, 2024 | Director | 17,500 | $46.38 | Sell | $811,650.00 | |
| March 22, 2024 | COO | 32,359 | $44.31 | Sell | $1,433,827.29 | |
| March 20, 2024 | Insider | 15,089 | $44.06 | Sell | $664,821.34 | |
| March 20, 2024 | Director | 60,000 | $44.14 | Sell | $2,648,400.00 | |
| March 19, 2024 | CFO | 6,942 | $42.91 | Sell | $297,881.22 | |
| Jan. 25, 2024 | Insider | 3,000 | $37.26 | Sell | $111,780.00 | |
| Jan. 10, 2024 | Insider | 3,000 | $37.65 | Sell | $112,950.00 | |
| Jan. 3, 2024 | Insider | 14,375 | $35.00 | Sell | $503,125.00 | |
| Jan. 2, 2024 | CFO | 10,000 | $35.47 | Sell | $354,700.00 | |
| Dec. 26, 2023 | Insider | 3,000 | $35.89 | Sell | $107,670.00 | |
| Dec. 21, 2023 | Insider | 9,583 | $34.57 | Sell | $331,284.31 | |
| Dec. 11, 2023 | Insider | 3,000 | $32.87 | Sell | $98,610.00 | |
| Nov. 27, 2023 | Insider | 3,000 | $31.84 | Sell | $95,520.00 | |
| Nov. 3, 2023 | CEO | 199,082 | $30.56 | Sell | $6,083,945.92 | |
| Nov. 1, 2023 | CFO | 10,000 | $28.75 | Sell | $287,500.00 |
Insiders are both buying and selling Crinetics Pharmaceuticals Inc stock.
The insider traders at Crinetics Pharmaceuticals Inc are: Stephen F Betz, Richard Scott Struthers, Dana Pizzuti, Vivo Capital Viii, Llc, Matthew K Fust, Marc Wilson, Jeff E Knight, Ventures Iv L.P. 5Am, Perceptive Advisors Llc, James Hassard, Alan Seth Krasner, Stephanie Okey, Coelho Rogerio Vivaldi, Life Sciences Maste Perceptive, Tobin Schilke, Ajay Madan, Fust Matthew K, and Vivo Capital Fund Viii, L.P.
The most active insider trader at Crinetics Pharmaceuticals Inc is Stephen F Betz with 39 trades.
Richard Scott Struthers has sold the most Crinetics Pharmaceuticals Inc stock with a total value of $22,739,674.11.
Perceptive Advisors Llc has bought the most Crinetics Pharmaceuticals Inc stock with a total value of $35,759,962.44.
The most recent insider trade for Crinetics Pharmaceuticals Inc was on March 16, 2026.
The single biggest insider buy for Crinetics Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $23,760,000.00 on Oct. 25, 2021.
The single biggest insider sell for Crinetics Pharmaceuticals Inc was from Vivo Capital Fund Viii, L.P. with a total value of $9,278,250.00 on March 20, 2019.
